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In recent years, there is growing evidence that plant-foods polyphenols, due to their biological properties, may be
unique nutraceuticals and supplementary treatments for various aspects of type 2 diabetes mellitus. In this article
we have reviewed the potential efficacies of polyphenols, including phenolic acids, flavonoids, stilbenes, lignans
and polymeric lignans, on metabolic disorders and complications induced by diabetes. Based on several in vitro,
animal models and some human studies, dietary plant polyphenols and polyphenol-rich products modulate
carbohydrate and lipid metabolism, attenuate hyperglycemia, dyslipidemia and insulin resistance, improve adipose
tissue metabolism, and alleviate oxidative stress and stress-sensitive signaling pathways and inflammatory processes.
Polyphenolic compounds can also prevent the development of long-term diabetes complications including
cardiovascular disease, neuropathy, nephropathy and retinopathy. Further investigations as human clinical studies
are needed to obtain the optimum dose and duration of supplementation with polyphenolic compounds in
diabetic patients.
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Type 2 diabetes is a complex metabolic disorder associ-
ated with developing insulin resistance, impaired insulin
signaling and β-cell dysfunction, abnormal glucose and
lipid metabolism, sub-clinical inflammation and increa-
sed oxidative stress; these metabolic disorders lead to
long-term pathogenic conditions including micro- and
macro-vascular complications, neuropathy, retinopathy,
nephropathy, and a consequent decrease in quality of life
and an increase in the rate of mortality [1-3]. Among
the multiple risk factors underling the incidence and
progression of type 2 diabetes, diet is the main modi-
fiable factor. An increasing number of epidemiological
investigations show that diet rich in foods with high-
content of phytochemicals, high total antioxidant capacity
and polyphenolic compounds may be related to lower risk
of diabetes and predisposing factors [4-9].
Based on the current understanding of pathophy-
siology of insulin resistance and type 2 diabetes, multiple* Correspondence: mirmiran@endocrine.ac.ir
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distribution, and reproduction in any mediumpharmacological and non-pharmacological interventions
have been developed with the aim of improving glycemic
control and prevention of diabetes complications; in this
area, recently the use of functional foods and their
bioactive components have been considered as a new
approach in the prevention and management of diabetes
and its complications [10-13].
Due to their biological properties, polyphenols may be
appropriate nutraceuticals and supplementary treat-
ments for various aspects of diabetes mellitus. Our aim
here is to review the current evidences in relation to
several potential efficacies of these bioactive components
on type 2 diabetes mellitus and related metabolic disor-
ders. We obtained relevant articles, including in vitro,
animal models and human studies with appropriate
design, as well as review articles with good quality,
published between 1990 to 2013, through searches of
the Medline and PubMed databases. We first describe a
brief introduction on dietary polyphenols, food sources
and properties, and then summarize the evidence from
in vitro, animal models and clinical studies.tral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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Polyphenols are natural phytochemical compounds in
plant-based foods, such as fruits, vegetables, whole grains,
cereal, legumes, tea, coffee, wine and cocoa; more than
8000 polyphenolic compounds, including phenolic acids,
flavonoids, stilbenes, lignans and polymeric lignans have
been identified in whole plant foods [5]. These com-
pounds are secondary metabolites of the plants that act as
a defense against ultraviolet radiation, oxidants and patho-
gens [14].
Polyphenols may be classified into several categories
based on the number of phenol rings and structural
elements that bind these rings to one another [15]. Phen-
olic acids are approximately a third of the polyphenolic
compounds in the diet and include two main classes
hydroxybenzoic acid derivatives (protocatechuic acid,
gallic acid, p-hydroxybenzoic acid) and hydroxycinnamic
acid derivatives (caffeic acid, chlorogenic acid, coumaric
acid, Ferulic acid, sinapic acid); berry fruits, kiwi, cherry,
apple, pear, chicory and coffee are the foods with high
content of these phenolic acids [16]. Flavonoids are the
most abundant polyphenols in the human diet and more
than 4000 types of these compounds have been identified.
There are six subclasses of flavonoids including an-
thocyanins, flavonols, flavanols, flavanones, flavones and
isoflavones; anthocyanins (cyanidin, pelargonidin, delphi-
nidin, malvidin) are found in the berries family, red wine,
red cabbage, cherry, black grape and strawberry. Flavo-
nols, including quercetin, kampferol and myricetin, have
been mainly detected in onion, curly kale, leeks, broccoli
and blueberries. Isoflavones are other most important
dietary flavonoids that include daidzein, genistein and
glycitein; soybeans and soy products are the richest
sources of these estrogen-like structure compounds.
Lignans, diphenoilc components with phytoesterogenic
activity, have been found in high concentrations in linseed
and other grains and cereals. Stilbenes occur in the human
diet in low quantities; resveratrol, one of the well studied
compounds of these groups, is largely detected in grapes
and red wine [5,16,17].
It is estimated that dietary intake of polyphenols is
approximately 1 g/day [18,19]. Bioavailability of these
bioactive components is dependent on food preparation
processes, gastrointestinal digestion, absorption and me-
tabolism [20]. During the absorption pathway, dietary
polyphenols must be hydrolyzed by the intestinal enzy-
mes or colonic microflora, and then be conjugated in
the intestinal cells and later in the liver by methylation,
sulfation or glucuronidation [21]. Polyphenols conse-
quently reach and accumulate in the target tissue and
induce biological properties; the polyphenol derivates
mainly excrete through bile and urine. Several studies
showed rapid absorption of the polyphenolic compounds,such as procyanidins, quercetin and flavanols into plasma,
with plasma concentrations peaking at 2 or 3 hours after
ingestion [16].
Several biological activities and beneficial properties
have been documented for dietary polyphenols, and some
of the more well known ones include antioxidant, anti-
allergic, anti-inflammatory, anti-viral and anti-microbial,
anti-proliferative, anti-mutagenic, anti-carcinogenic,
free radical scavenging, regulation of cell cycle arrest,
apoptosis, and induction of antioxidant enzymes; more
interestingly, dietary polyphenols could modulate some
important cell signaling pathways such as nuclear factor
kappa-B (NF-κB), activator protein-1 DNA binding
(AP-1), extracellular signal-regulated protein kinase
(ERK), phosphoinositide 3 (PI3) kinase/protein kinase B
(Akt), mitogen-activated protein kinases (MAPK), and
nuclear factor erythroid 2 related factor 2 (Nrf2) [22].
Anti-hyperglycemic effects of polyphenols with regard to
carbohydrate metabolism, β-cell function and insulin
resistance
Impaired carbohydrate metabolism and developing
insulin resistance is the main metabolic disorder in non-
insulin dependent diabetes mellitus leading to hyper-
glycemia. Altered digestion and absorption of dietary
carbohydrate, depletion of glycogen storage, increased
gluconeogenesis and over output hepatic glucose, β-cell
dysfunction, insulin resistance of peripheral tissue and
defect in insulin signaling pathways are more important
causes of hyperglycemia [23]. Although the use of oral
anti-diabetic drugs including α-glucosidase inhibitors,
biguanides, meglitinides, sulfonylureas, thiazolidindiones
or insulin therapies are common clinical options in
management of type 2 diabetes and hyperglycemia, but
traditionally used natural agents have been considered
for a long period of time. Among the known natural
bioactive components and phytochemicals, recently
polyphenols are very popular because of their anti-
hyperglycemic effects, safety and non side-effects. Poten-
tial efficacy of polyphenols on carbohydrate metabolism
and glucose homeostasis has been well investigated in
in vitro, animal models and some clinical trials [24].
In Figure 1 beneficial effects of polyphenols on mana-
gement of blood glucose in diabetes are summarized.
The hypoglycemic effects of polyphenols are mainly
attributed to reduce intestinal absorption of dietary
carbohydrate, modulation of the enzymes involved in
glucose metabolism, improvement of β-cell function and
insulin action, stimulation of insulin secretion, and the
antioxidative and anti-inflammatory properties of these
components [25-27].
One of the most well known properties of the polyphe-
nols, especially flavonoids, phenolic acids and tannins, on
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Figure 1 Beneficial effects of polyphenols on management of blood glucose in diabetes. The hypoglycemic effects of polyphenols are
mainly attributed to reduce intestinal absorption of dietary carbohydrate, modulation of the enzymes involved in glucose metabolism,
improvement of β-cell function and insulin action, and stimulation of insulin secretion.
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of dietary carbohydrates to glucose [26,28]. Some polyphe-
nols, including green tea catechins and epicatechins,
chlorogenic acids, Ferulic acids, caffeic and tannic acids,
quercetin and naringenin, could interact with absorption
of glucose from intestine via inhibition of Na+-dependent
glucose transporters, SGLT1 and SGLT2 [29,30]. Some
investigations have shown that polyphenolic compounds
are also able to regulate postprandial glycemia and inhibit
the development of glucose intolerance by a facilitated
insulin response and attenuated secretion of glucose-
dependent insulinotropic polypeptide (GIP) and glucagon-
like polypeptide-1 (GLP-1) [31,32].
Some polyphenols are able to regulate the key path-
ways of carbohydrate metabolism and hepatic glucose
homeostasis including glycolysis, glycogenesis and glu-
coneogenesis, usually impaired in diabetes. Ferulic acid,
a hydroxycinnamic acid derivate, effectively suppresses
blood glucose by elevating glucokinase activity and
production of glycogen in the liver and increased plasma
insulin levels in diabetic rats [33]. Supplementation of
diabetic rats with hesperidin and naringin, two main
citrus bioflavonoids, was accompanied with increased
hepatic glucokinase activity and glycogen content, atten-
uated hepatic gluconeogenesis via decrease the activityof glucose-6-phosphatase and phosphoenolpyruvate
carboxykinase (PEPCK), and subsequent improvement
of glycemic control [34,35]. Green tea polyphenols,
mainly catechins and epicatechins have been shown to
attenuate hyperglycemia and hepatic glucose output via
downregulation the expression of liver glucokinase and
upregulation of PEPCK [36]; in an in vitro study, epigal-
locatechin gallate (EGCG), one of the most abundant
catechins in green tea, could activate AMP-activated
protein kinase as a required pathway for the inhibition of
gluconeogenic enzymes expression [37].
Dietary polyphenols also influence peripheral glucose
uptake in both insulin sensitive and non-insulin sensitive
tissues; one study showed that phenolic acids stimulated
glucose uptake by comparable performance to metformin
and thiazolodinedione, main common oral hypoglycemic
drugs [38]. The results from the in vitro studies showed
that some polyphenolic compounds such as quercetin,
resveratrol and EGCG improved insulin-dependent glu-
cose uptake in muscle cells and adipocytes by transloca-
tion of glucose transporter, GLUT4, to plasma membrane
mainly through induction of the AMP-activated protein
kinase (AMPK) pathway [39,40]. AMPK, an important
sensor of cellular energy status, has a key role in metabolic
control; activation of this pathway is considered as a new
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and a main target for anti-diabetic drugs including met-
formin [41,42]. Interestingly, effect of polyphenols in
activation of AMPK has been reported 50-200 times
more than metformin [43]. Some polyphenols also have
potential to induce phosphatidylinositide 3-kinase (PI3k)
as a key signaling pathway for up-regulation of glucose
uptake [44].
Isoflavones, particularly genistein, have amazing effects
on pancreatic β-cells; Liu et al reported that anti-
diabetic effects of genistein are not associated with
stimulation of insulin synthesis, expression of glucose
tranporter-2 or glycolytic pathway, genistein acts as a
novel agonist of cyclic AMP/protein kinas A signaling,
an important physiological amplifier of glucose-induced
insulin secretion by the pancreatic β-cells [45,46].
Furthermore, Fu et al indicated that genistein could in-
duce protein expression of cyclin D1, a major cell-cycle
regulator of β-cell growth and subsequently improve
islet β-cell proliferation, survival and mass [47].
Hyperglycemia-induced oxidative stress in pancreatic
β-cells plays a pivotal role in the development of
diabetes [48,49]. Some of the polyphenolic compounds
protect β-cells from hyperglycemia-induced and oxidative-
induced damage; oral administration of phenolic-rich
chestnut extract in STZ-induced diabetic rats had favo-
rable effects on serum glucose and viability of β-cell
through attenuation of oxidative stress, enhancing the
natural antioxidant system, and inhibition of lipid peroxi-
dation [50]. Another very known phenolic compound,
resveratrol (3,4′,5-trihydroxystilbene) found in grapes,
wine, grape juice, peanuts, and berries, improve glucose
tolerance, attenuate β-cell loss, and reduce oxidative stress
in pancreatic islet [51]. Resveratrol also alleviate chronic
over stimulation induced-workload and impose pressure
on the β-cells, and subsequently delay the degradation of
pancreatic islets and progress of type 2 diabetes. This
effect appears to be due to the diminished stimulatory
effects of hyperglycemia in insulin secretion; some expe-
rimental and in vitro studies demonstrated that resveratrol
has the potential to reduce insulin secretion through
induction of metabolic changes in β-cells [51,52].
Some protective effects of polyphenols on β-cells are
related to the ability to modulate key cellular signaling
pathways; anthocyanins-rich Chinese bayberry extract
showed protective effects for pancreatic β cells against oxi-
dative damage through up-regulation of heme oxygenase-1,
modulation of ERK1/2 and PI3K/Akt signaling pathway
and inhibition of β cells apoptosis [39].
In summary, results of the studies acknowledge that plant
polyphenols favorably affect several aspects of diabetes-
induced metabolic disorders and modulate carbohydrate
metabolism, glucose homeostasis, insulin secretion and
insulin resistance.Cardiovascular protective effects of polyphenols with
regard to lipid metabolism, blood pressure, blood
coagulation and vascular function
Progressive insulin resistance is mainly accompanied with
pro-atherogenic cardiovascular risk profiles and conse-
quently atherosclerotic coronary artery disease and other
forms of cardiovascular disease are the major causes of
mortality in type 2 diabetic patients [53]. Dyslipidemia,
undesirable changes in vascular endothelial and smooth
muscle cells, lipid peroxidation especially oxidized low-
density lipoprotein particles, oxidative damage and increa-
sed inflammatory mediators including chemokines and
cytokines, hyper-coagulation and platelet activation
have been considered as the main metabolic abnor-
malities in diabetes mellitus leading to cardiovascular
disease [54].
There is growing evidence suggesting that dietary
intake of polyphenol-rich foods and supplementation with
these bioactive components could have protective effects
against diabetes-induced cardiovascular pathogenesis; the
mechanisms involved in these properties mainly include
regulation of lipid metabolism, attenuation of oxidative
damage and scavenging of free radicals, improvement of
the endothelial function and vascular tone, enhancement
the production of vasodilating factors such as nitric oxide,
and inhibition the synthesis of vasoconstrictors such as
endothelin-1 in endothelial cells [55-57].
One of the most important favorable effects of poly-
phenols on cardiovascular system in diabetes probably is
regulation of lipid and lipoprotein metabolism, and impro-
vement of dyslipidemia. Based on research conducted in
this area, polyphenolic compounds are capable of redu-
cing digestion and absorption of dietary lipids. Oligomeric
procyanidins, contained in apples had inhibitory effects on
pancreatic lipase and triglyceride absorption [58]. Apple
procyanidins also induce hypolipidemic effects by decreas-
ing of apolipoprotein B synthesis and secretion, inhibition
of cholesterol estrification and intestinal lipoprotein pro-
duction [59]. The hypolipidemic effects of catechins and
proanthcyanidins are related to inhibition of key enzymes
in lipid biosynthesis pathways, reduce intestinal lipid
absorption. Catechins also interact with proteins involved
in cholesterol translocation from the enterocyte brush
border (ATP-binding cassette proteins, multidrug re-
sistance P-glycoprotein 1, B type1-scavenger receptors,
Niemann Pick C-1 like 1 protein), change their function
and effectively reduce cholesterol absorption [60]. Admin-
istration of tart cherries as medicinal food rich in anthocy-
anins was accompanied with decrease in hyperlipidemia,
hyperinsulinemia, fatty liver and hepatic steatosis through
enhanced hepatic PPARα and some target genes including
acyl-coenzyme A oxidase [61].
Endothelial dysfunction, proliferation and migration of
smooth muscle cells of the vessels are central events in
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Some cardiovascular protective properties of polyphe-
nols are attributed to modulatory effects on the vascular
structure and function. Interestingly, some polyphenols
inhibit the expression of major proangiogenic, proth-
rombotic and proatherosclerotic factors such as mo-
nocyte chemoattractant protein-1, vascular endothelial
growth factor (VEGF) and matrix metalloproteinase-2
(MMP-2) in smooth muscle cells, by redox-sensitive
and redox-insensitive mechanisms [62-64]. Oligomeric
proanthcyanidins, found in red apple, cinnamon, cocoa,
and grapes have the potential to protect vascular cell
against diabetes-induced oxidative stress via increase in
activity of superoxide, dismutase inhibition of NADPH
oxidase and production of free radicals as well as
decrease proliferation of smooth muscle cells [65].
Flanan-3-ols modulate platelet hyperactivity and aggre-
gation, regulate coronary blood flow, reduce endothelial
inflammatory cytokines and free radicals, increase
production and bioavailability of nitric oxide, and con-
sequently atherosclerosis development [66]. In human
trials, consumption of high-polyphenol dark chocolate
was accompanied with improvement of endothelial func-
tion in individuals with stage 1 hypertension, and attenu-
ation acute transient hyperglycemia-induced endothelial
dysfunction and oxidative stress in type 2 diabetic patients
[67,68]. Administration of other polyphenol-rich products
such as grape seed extract, cranberry juice, grape and
pomegranate juice also had a therapeutic role in decrea-
sing cardiovascular risk factors in patients with type 2
diabetes and metabolic syndrome [69,70].
Catechins, quercetin and anthocyanins have potent
platelet-inhibitory properties and are considered as
inhibitors of platelet cell signaling and thrombus for-
mation [71]. As reviewed by Pascul-Tresa, bioactive
anthocyanins including delphinidin-3-rotinoside, cyanidin-
3-glucoside, cyanidin-3-rutinoside, malvidin-3-glucoside
and intestinal metabolites such as dihydroferulic acid and
3- (hydroxyphenyl) propionic acid prevent platelet hyper-
activation and aggregation through inhibition of peptides
activating thrombin receptor [66].
Undoubtedly, one of the main protective properties of
polyphenols in the development of cardiovascular
dysfunction in diabetic condition is related to the ability
of these bioactive components to prevent lipoproteins
oxidation and production of advanced glycation end
products. Dietary polyphenolic compounds also protect
myocardial tissue against several undesirable changes
and diabetic cardiomyopathy. Treatment of diabetic rat
models with grape seed proanthcyanidins extracts effec-
tively reduced the receptor of advanced glycation end
products (RAGE), nuclear factor-kappaB (NF-kappaB),
and transforming growth factor-β (TGF-β) gene expres-
sion in myocardial tissue [72].Human studies have confirmed the benefits of poly-
phenols on the cardiovascular system; Rizza et al in a
randomized cross-over clinical trial shown that oral
administration (50 mg/d for 3 week) of hesperidin, a
citrus flavonoids, increased flow mediated dilation and
reduced circulating inflammatory biomarkers (hs-CRP,
serum amyloid A protein, soluble E selectin), decreased
adhesion of monocytes, expression of vascular cell adhe-
sion moleculs-1 and generally improved vascular function
in patients with metabolic syndrome [73]. Another cross-
over trial conducted in postmenopausal type 2 diabetic
patients, showed that supplementation with isoflavones
from red clover (50 mg/day) after 4 weeks improved endo-
thelial function and decrease systolic and diastolic blood
pressure [74].
In summary, results of the studies confirm that poly-
phenolic compounds attenuate several cardiovascular risk
factors in diabetes; dietary polyphenols modulate lipid
metabolism and dyslipidemia, improve vascular function,
decrease oxidative and inflammatory-induced vascular
damage, and regulate blood pressure.
Antioxidative properties of polyphenols
One of the pathogenic mechanisms that explain the
development and progression of micro and macro vascu-
lar complications in diabetes is oxidative stress; increased
generation of free radicals and an impaired antioxidant
defense system in diabetic conditions induces imbalance
of the oxidant/antioxidant status [2,75]. Inhibition of these
oxidative processes could prevent the onset and develop-
ment of long-term diabetic complications [76].
Most polyphenolic compounds and their active metabo-
lites have been known as potent antioxidant phytoche-
micals due to their unique structure. As reviewed by
Dembinska-Kiec, these compounds could scavenge free
radicals, quench electronically excited compounds, reduce
hydroperoxide formation, and attenuate production of
reactive oxygen species (ROS) through modulation of
several enzymes involved in the development of ROS
including xanthine oxidase, cyclooxygenase, lipoxygenase,
microsomal monooxygenase, NADH oxidase and mito-
chondrial succinoxidase [77]. Some experts believe that
polyphenols beyond the direct antioxidant capacities in
scavenging of free radicals mainly act by direct interac-
tions with important cellular receptors or key signaling
pathways, which may result in modification of the redox
status of the cell and may trigger a series of redox-
dependent reactions [78].
Plant polyphenols can enhance the endogenous
antioxidative system, improve oxidant antioxidant balance,
and effectively prevent oxidative damage; green tea
catechins are the polyphenolic compounds most studied
polyphenolic compounds in this area; these bioactive com-
ponents decreased lipid peroxidation and increased
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stress-sensitive signaling pathways, prooxidant enzymes,
and inducted of antioxidant enzymes including superoxide
dismutase, catalase and glutathione peroxidase [79].
In summary, polyphenols effectively attenuate oxidative
stress, promote endogenous antioxidant defense system,
and modulate oxidant/antioxidant balance.
Effects of polyphenols on adipose tissue metabolism
Adipocyte dysfunction is strongly associated with the
development of insulin resistance, sub-clinical inflamma-
tion, β cell impairment and type 2 diabetes [80]. Poly-
phenolic compounds have wonderful modulatory effects
on many aspects of metabolic, endocrine and cellular sig-
naling transduction of adipose tissue. Some polyphenols
such as catechins increase β oxidation in adipocytes,
down-regulate the enzymes and genes involved in lipo-
genesis including lipoprotein lipase, fatty acid synthase
complex, peroxisome proliferator-activated receptor γ
(PPARγ), CCAAT enhancer-binding protein-α, regulatory
element-binding protein 1-c, fatty acid binding protein.
Some polyphenols, up-regulate lipolysis pathways via in-
duction of hormone sensitive lipase, adipose tissue lipase,
increased gene expression of mitochondrial uncoupling
protein 2 (UCP-2) and carnitin palmitoyl transferase-1
(CPT-1) in adipocytes [81,82].
Anthocyanins, one group of phenolic compounds con-
sidered as modulators of adipose tissue metabolism, are
bioactive components which improve adipocytes dysfunc-
tion and adipocytokines secretion in insulin resistance,
increase β oxidation and decrease fat accumulation on
adipocytes [83]. Cyanidin and cyanidin-3-glucoside have
shown several therapeutic effects on adipocyte dysfunction
through decrease in plasminogen activator inhibitor-1 and
interleukin-6, induction of mitochondrial uncoupling pro-
teins, acetyl CoA oxidase, perlipin and adiponectin gene
expression [84].
Favorable effects of polyphenols in prevention of long-
term diabetes complications
One of the most important properties of polyphenols re-
cently identified is its preventive effect against long-term
diabetes complications including retinopathy, nephropa-
thy and neuropathy; based on research conducted in this
area administration of anthocyanins, flavonoids and
other polyphenolic compounds in diabetic conditions
may facilitate new approaches for improving the quality
of life in diabetic patients.
As reviewed by Ghosh et al, anthocyanins and antho-
cyanins-rich extracts have the potential to alleviate the
developing pathways of some pathologic conditions
related to diabetes; anthocyanins facilitate blood flow and
prevent diabetes-induced microangiopathy, increase micro-
vascular permeability, decrease leucocytes aggregation invascular cell wall and improve capillary filtration of
albumin [85]. Purple corn extract containing cyanidin 3-
glucoside and cyanidin-3-(6″-malonylglucoside) attenuated
hyperglycemia-induced mesangial cell proliferation and
matrix accumulation, and inhibited over-expression
intracellular cell adhesion molecule-1 and monocyte
chemoattractant protein-1, as major features of diabetic
mesangial fibrosis and glomerulosclerosis [86]. Recently
there has been increasing interest in grape seed proan-
thcyanidin extracts as a natural treatment for some
important diabetes complications; proanthcyanidin-rich
grape seed extract inhibited the development of reti-
nopathy, nephropathy and neurodegenerative damage in
diabetic condition [87,88].
Flavanols surprisingly have the potential to improve
cognitive disorders and cholinergic dysfunction related
to diabetes and other secondary consequence of changes
in the nervous system induced by hyperglycemia and
diabetes oxidative stress; administration of quercetin in
diabetic rats improved mental function and memory via
inhibition of acetylcholine esterase and attenuation of
oxidative damage in nervous system [89].
Green tea catechins including epicatechin, epicatechin-
3-gallat, and epigalocatechin gallat decreased the synthesis
of thromboxane A2 (TXA2) and increased prostacyclin I2
(PGI2), modulate the impaired balance between these
ecosanoids as accelerators of thrombogenesis in the renal
tubules, leading consequently improved glomerular fil-
tration and kidney function [90].
Conclusion
Type 2 diabetes, a clustering of metabolic disorder, is
accompanied with other pathogenic conditions including
sub-clinical inflammation and oxidative stress that subse-
quently leads to insulin resistance and long-term diabetes
complications. The rising trend in the prevalence of dia-
betes complications suggests that current medical treat-
ments for the management of diabetes are not sufficient
and use of supplementary treatments, including functional
foods and their nutraceuticals, could increase the effecti-
veness of diabetes management. Plant polyphenols inclu-
ding phenolic acids, flavonoids, stilbenes and lignans,
based on in vitro studies, animal models and some clinical
trials, have been proposed as effective supplements for
diabetes management and prevention of its long-term
complications. Further investigations using human clinical
studies are needed to confirm the beneficial effects of
polyphenolic compounds as supplementary treatments for
diabetic patients.
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